Monica Marvin, M.S., CGC

Monica Marvin, M.S., CGC

Director Genetic Counseling Program
Clinical Associate Professor of Human Genetics
Clinical Associate Professor of Internal Medicine

4914 Buhl
1241 E. Catherine St.
Ann Arbor, MI 48109-5618


Administrative Contact

Areas of Interest

Improving access to genetic counseling through alternate service delivery models.

Psychosocial outcomes of genetic counseling and genetic testing for inherited cancer syndromes.

Expansion of clinical descriptions of novel inherited cancer syndromes, such as hereditary paraganglioma syndrome and AXIN2-associated autosomal dominant ectodermal dysplasia and neoplastic syndrome.

Honors & Awards

  • 2010 “Leaders Among Us” recognition, National Society of Genetic Counselors
  • 2014 Strategic Leader Award, National Society of Genetic Counselors
  • 2016 Rackham Master's Mentoring Award, University of Michigan


  • 1994 M.S. University of Michigan

Published Articles or Reviews

Read P, Yashar BM, Robinson L, Marvin M: Optimizing efficiency and skill utilization: Analysis of genetic counselors' attitudes regarding delegation in a clinical setting. J Genet Couns. 2019 Nov 13. [Epub ahead of print]

Miller I, Greenberg S, Yashar BM, Marvin ML: Improving access to cancer genetic services: perspectives of high-risk clients in a community-based setting. J Community Genet: 2019. [Epub ahead of print]

Greenberg S, Yashar BM, Pearlman M, Duquette D, Milliron K, Marvin M: Evaluating and improving the implementation of a community-based hereditary cancer screening program. J Community Genet, 10(1):51-60, 2019.

Arscott P, Caleshu C, Kotzer K, Kreykes S, Kruisselbrink T, Orland K, Rigelsky C, Smith E, Spoonamore K, Haidle JL, Marvin M, Ackerman MJ, Hadi A, Mani A, Ommen S, Cherny S: A Case for Inclusion of Genetic Counselors in Cardiac Care: A Case for Genetic Counselors. Cardiology in review: 2015.

Gustafson SL, Raymond VM, Marvin ML, Else T, Koeppe E, Stoffel EM, Everett JN: Outcomes of genetic evaluation for hereditary cancer syndromes in unaffected individuals. Familial cancer 14(1): 167-74, 2015.

Everett JN, Raymond VM, Dandapani M, Marvin M, Kohlmann W, Chittenden A, Koeppe E, Gustafson SL, Else T, Fullen DR, Johnson TM, Syngal S, Gruber SB, Stoffel EM: Screening for germline mismatch repair mutations following diagnosis of sebaceous neoplasm. JAMA dermatology 150(12): 1315-21, 2014.

Else T, Marvin ML, Everett JN, Gruber SB, Arts HA, Stoffel EM, Auchus RJ, Raymond VM: The clinical phenotype of SDHC-associated hereditary paraganglioma syndrome (PGL3) J. Clin. Endocrinol. Metab. 99(8): E1482-E1486, 2014.

Cohen SA, Marvin ML, Riley BD, Vig HS, Rousseau JA, Gustafson SL. Identification of genetic counseling service delivery models in practice: a report from the NSGC Service Delivery Model Task Force. J Genet Couns. 22(4):411-21. 2013

Banks KC, Moline JJ, Marvin ML, Newlin AC, Vogel KJ. 10 rare tumors that warrant a genetics referral. Fam Cancer. 12(1):1-18, 2013.

Cohen, SA, Gustafson SL, Marvin ML, Riley BD, Uhlmann WR, Liebers SB, Rousseau JA. “Report from the National Society of Genetic Counselors service delivery model task force: a proposal to define models, components, and modes of referral.” J Genet Couns. 21(5):645-51, 2012.

Owens KM, Marvin ML, Gelehrter TD, Ruffin MT, Uhlmann WR. Clinical Use of the Surgeon General's "My Family Health Portrait" (MFHP) Tool: Opinions of Future Health Care Providers. J Genet Couns. 20 (5): 510-25, 2011.

Marvin ML, Mazzoni SM, Herron CM, Edwards S, Gruber SB, Petty EM. AXIN2-associated autosomal dominant ectodermal dysplasia and neoplastic syndrome. Am J Med Genet. 155A(4):898-902, 2011.

Marvin M, Bradford C, Sisson J, Gruber SB. Diagnosis and management of hereditary paraganglioma syndrome due to the F933>X67 SDHD mutation. Head and Neck, 31(5):689-94, 2009.

Kelly K, Leventhal H, Andrykowski M, Toppmeyer D, Much J, Dermody J, Marvin M, Baran J, Schwalb M. Using the common sense model to understand perceived cancer risk in individuals testing for BRCA1/2 mutations. Psycho oncology, 14(1): 34-48, 2005.

Kelly K, Leventhal H, Andrykowski M, Toppmeyer D, Much J, Dermody J, Marvin M, Baran J, Schwalb M. The decision to test in individuals receiving genetic counseling for BRCA1 and BRCA2 mutations. Journal of Genetic Counseling, 13(3), 237-257, 2004.

Kelly K. Leventhal H, Marvin M, Toppmeyer D, Baran J, Schwalb M. Knowledge and beliefs about cancer genetics and the decision to test in Ashkenazi Jewish individuals receiving counseling for BRCA1/2 mutations. Cancer Control, 11(4):236-44, 2004.

Kelly K, Leventhal H, Marvin M, Toppmeyer D, Dermody, J, Baran J, Schwalb M. Subjective and objective risk of breast cancer in Ashkenazi Jewish individuals at risk for BRCA1/2 mutations. Genetic Testing, 8(2): 139-147, 2004.

Hoedema R, Monroe T, Bos C, Palmer S, Kim D, Marvin M, Luchtefeld M. Genetic testing for hereditary nonpolyposis colorectal cancer. American Surgeon, 69(5): 378-391, 2003.

Kelly K, Leventhal H, Toppmeyer D, Much J, Dermody J, Marvin M, Baran J, and Schwalb, M. Subjective and objective risks of carrying a BRCA1/2 mutation in individuals of Ashkenazi Jewish descent. Journal of Genetic Counseling, 12(4): 351-372, 2003.

McKinnon W, Baty B, Bennett R, Magee M, Neufeld-Kaiser W, Peters K, Sawyer J, and Schneider K. Predisposition genetic testing for late-onset disorders in adults: A position paper of the National Society of Genetic Counselors. Journal of American Medical Association, 278(15):1217-1220, 1997.

Web Sites